Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Cardiac Tissue Engineering Market Today And What Is Its Future Size?

The market for cardiac tissue engineering has been expanding swiftly over the past few years. A notable growth from $0.67 billion in 2024 to $0.8 billion in 2025, indicating a compound annual growth rate (CAGR) of 19.4%, is expected. The expansion during the past few years is linked to the scarcity of organ donors, a steady rise in cardiovascular diseases, advancements in biomaterials, increased investment in regenerative medicine, personalized medicine demand, development in bioreactor systems, escalated government support for biomedical studies, and an increased emphasis on less invasive treatments.

Anticipated swift enlargement in the upcoming years is projected for the cardiac tissue engineering market, escalating to $1.62 billion in 2029 with a compound annual growth rate (CAGR) of 19.2%. A surge in personalized cardiac treatment requirements, a heightened emphasis on bioengineered heart tissues, the broadening scope of regenerative medicine applications, a rise in alliances between biotech organizations and academic institutions, an increment in investment towards preclinical testing platforms, and an uptick in chronic heart disease incidence, all contribute to this growth during the forecast period. Significant trends expected in this period cover the assimilation of AI into tissue engineering, progress in nanotechnology-based scaffolding, the emergence of biodegradable hydrogels, advancements in the accuracy of 3D bioprinting, the employment of bioreactors for tissue maturation, and the application of gene editing for cardiac cell improvement.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21129&type=smp

What External And Internal Drivers Are Influencing The Cardiac Tissue Engineering Market?

The cardiac tissue engineering market is set to grow due to an escalating prevalence of cardiovascular diseases. The intent of cardiac tissue engineering, a cross-disciplinary field, is to create bioartificial or biological constructs to replace, regenerate, or repair damaged heart tissue. Unhealthy lifestyle practices including a poor diet, physical inactivity, increased obesity and diabetes rates, and smoking mainly drive the surge in cardiovascular diseases. Cardiac tissue engineering aims to develop biomaterials, bioengineered tissues, and cell-based therapies in response to cardiovascular diseases, intending to restore cardiac function and regenerate or repair damaged heart muscles. For instance, as reported by the US-based governmental agency, the Centers for Disease Control and Prevention, there was a minor rise in the percentage of coronary heart disease in adult women aged 18 and above, from 3.6% in 2022 to 3.7% in May 2023. Thus, the escalating prevalence of cardiovascular diseases continues to fuel the expansion of the cardiac tissue engineering market.

How Is The Cardiac Tissue Engineering Market Categorized Across Applications And Types?

The cardiac tissue engineeringmarket covered in this report is segmented –

1) By Product: Heart Valves, Vascular Grafts

2) By Material: Stem Cells, Scaffolds

3) By Application: Myocardial Infarction, Heart Valve Repair Or Replacement, Congenital Heart Disease Treatment, Other Applications

4) By End Users: Hospitals And Clinics, Academic And Research Institutes, Other End Users

Subsegments:

1) By Heart Valves: Bioprosthetic Heart Valves; Mechanical Heart Valves; Tissue-Engineered Heart Valves

2) By Vascular Grafts: Synthetic Vascular Grafts; Biologic Vascular Grafts; Tissue-Engineered Vascular Grafts

How Are Industry Trends Steering The Expansion Of The Cardiac Tissue Engineering Market?

Key players in the cardiac tissue engineering market are striving to make technological leaps, such as the development of 3D-engineered muscle tissues, in an effort to improve the precision and efficacy of drug discovery for reliable cardiovascular disease treatments. 3D-engineered muscle tissues are bioengineered constructs which mimic the structure and function of human muscle, primarily utilized for drug testing and disease modeling. For instance, Curi Bio Inc., a biotech firm based in the US, introduced the Mantarray platform in July 2022, designed for 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis. The platform employs advanced tissue culture methodologies to create highly functional muscle tissues which simulate the mechanical properties and behavior of natural muscle, presenting a more accurate model for drug testing. The technology is aimed at boosting the development of therapeutic remedies by enabling researchers to examine muscle contraction, reaction to stimuli, and disease modeling at the cellular level.

Who Are The Global Leaders Steering The Cardiac Tissue Engineering Market Forward?

Major companies operating in the cardiac tissue engineering market are Biotronik SE & Co. KG, Terumo Corporation, Artivion Inc., Tissue Regenix Group plc, PromoCell GmbH, Xeltis AG, Carmat S.A., Bioheart Inc., Prellis Biologics Inc., Cytograft Tissue Engineering Inc., Avery Therapeutics Inc., Vascudyne Inc., Auto Tissue Berlin GmbH, CorMatrix Cardiovascular Inc., Humacyte Inc., BioCardia Inc., Osiris Therapeutics Inc., StemCells Inc., ViroMed Co. Ltd., Cardio3 Biosciences

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-tissue-engineering-global-market-report

What Are The Emerging Regional Trends Driving The Cardiac Tissue Engineering Market?

North America was the largest region in the cardiac tissue engineering market in 2024. The regions covered in the cardiac tissue engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21129&type=smp

Browse Through More Reports Similar to the Global Cardiac Tissue Engineering Market 2025, By The Business Research Company

Implantable Cardiac Rhythm Management Device Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-cardiac-rhythm-management-device-global-market-report

Cardiac Safety Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-safety-services-global-market-report

Cardiac Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model